A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

Name: A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine
License: Public Domain

Sinocelltech Ltd.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

covid

covid-19 pandemic

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 623540
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.